TANNQUILYNNE
Live / Registered — Registered (as of 30 Mar 2021)
What this means for you
Registered since 30 Mar 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87914117
- Registration number
- 6303591
- Mark type
- Stylized text
- Filed
- 09 May 2018
- Published for opposition
- 12 Jan 2021
- Registered
- 30 Mar 2021
- Attorney of record
- Michael T. Smith
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Phenol for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Syrups for pharmaceutical purposes for the treatment of dementia; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for treating sunburn; Chemical reagents for medical or veterinary purposes; Adjuvants for medical purposes; Animal feed additive for use as a nutritional supplement for medical purposes; Medicinal herbal extracts for medical purposes; Antibacterial substances for medical purposes; Transdermal patches featuring medication for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Nutritional food additives for medical purposes in the nature of natural food extracts derived from plant; Herbal extracts for medical purposes; Phytotherapy preparations for medical purposes; Appetite suppressants for medical purposes; Beverages containing tannic acid for use as a nutritional supplement; Liquid nutritional supplement; Dietary and nutritional supplements; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Powdered nutritional supplement drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplements consisting primarily of tannic acid; Dietary and nutritional supplements used for weight loss; Nutritional supplement shakes; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements in capsule form for dogs; Nutritional supplements; Nutritional supplement for eliminating toxins from the body; Nutritionally fortified water for medical purposes; Nutritionally fortified beverages for medical purposes; Vitamin fortified beverages for medical purposes; Vitamin enriched chewing gum for medical purposes; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Powdered nutritional supplement drink mix containing tannic acid; Nutritional supplements for cats, dogs; Nutraceuticals for use as a dietary supplement for cognitive impairment; Nutraceuticals for the treatment of CNS disorders; Nutraceuticals for use as a dietary supplement
Owner
- SYNEURX NEUROSCIENCE, GRAND CAYMAN, KY
- SyneuRx International (Taiwan) Corp., New Taipei City, TW
- SyneuRx International (Taiwan) Corp., New Taipei City, TW
- SyneuRx International (Taiwan) Corp., New Taipei City 221, TW
Prosecution history
- 30 Mar 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Jan 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 30 Mar 2021 — REGISTERED-PRINCIPAL REGISTER
- 12 Jan 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Jan 2021 — PUBLISHED FOR OPPOSITION
- 23 Dec 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Dec 2020 — CASE RETURNED TO EXAMINATION
- 09 Dec 2020 — NOTICE OF ALLOWANCE CANCELLED
- 02 Dec 2020 — ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
- 02 Dec 2020 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 01 Dec 2020 — ASSIGNED TO PETITION STAFF
- 02 Nov 2020 — ASSIGNED TO EXAMINER
- 01 Oct 2020 — TEAS PETITION TO AMEND BASIS RECEIVED
- 28 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jul 2020 — SOU EXTENSION 3 GRANTED